AMG National Trust Bank’s FibroBiologics FBLG Stock Holding History

AMG National Trust Bank’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,948	Closed	-$31.3K	–	497
2025 Q4	$31.3K	Buy	+6,948	New	+$48.9K	﹤0.01%	453

Other funds holding FBLG

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FEG

Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFP

Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

VGA

Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

AMG National Trust Bank's FBLG Position: Q1 2026 in Review

AMG National Trust Bank sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 6,948 shares — an estimated $31.3K sold.

AMG National Trust Bank first reported a position in FBLG in Q4 2025 and held it in 1 quarter. The position peaked at $31.3K in Q4 2025. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

AMG National Trust Bank reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
AMG National Trust Bank sold 6,948 FibroBiologics shares in Q1 2026, an estimated $31.3K.
AMG National Trust Bank first reported a position in FibroBiologics in Q4 2025 and held it in 1 quarter.
AMG National Trust Bank's FibroBiologics position peaked at $31.3K in Q4 2025.
17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on AMG National Trust Bank's 13F filing for Q1 2026, filed 4 May 2026.